Iradimed (NASDAQ:IRMD) reported Q4 2017 earnings this Morning, coming in at $0.10 per share, beating Wall Street’s estimates of $0.02 per Share. Revenue for the quarter came in at $6.70 million missing the streets estimates of $6.72 million Recent Insider Trading for Iradimed (NASDAQ:IRMD)
- On 12/4/2017 Monty K Allen, Director, sold 1,898 with an average share price of $13.95 per share and the total transaction amounting to $26,477.10.
- On 6/1/2017 Steven M Nardi, VP, sold 4,634 with an average share price of $8.32 per share and the total transaction amounting to $38,554.88.
- On 2/9/2017 Roger E Susi, CEO, bought 10,000 with an average share price of $8.60 per share and the total transaction amounting to $86,000.00.
- On 11/29/2016 Roger E Susi, CEO, bought 5,000 with an average share price of $11.24 per share and the total transaction amounting to $56,200.00.
- On 11/15/2016 Roger E Susi, CEO, bought 5,000 with an average share price of $10.46 per share and the total transaction amounting to $52,300.00.
- On 8/16/2016 Steven M Nardi, VP, sold 2,096 with an average share price of $17.11 per share and the total transaction amounting to $35,862.56.
Recent Trading for Iradimed (NASDAQ:IRMD) Shares of Iradimed closed the previous trading session at 15.05 +0.00 0.00% with 633 shares trading hands.